21st February 2006

NOWGEN Centre

Manchester

09:15

Registration and Coffee

 Session One

Novel Treatments for Retinal Disease

 10:00-10:30

Update of Gene Therapy Modalities – the RPE65 Trial – Tony Moore, UCL

 10:30-11:00

Stem Cells in the Treatment of Retinal Dystrophies – Robert McLaren, UCL

 11:00-11:30

Opticin: a Vitreous-Derived Anti-Angiogenic? – Paul Bishop, Manchester

 11:30-12:30

Session Two:  Unusual Cases from the Floor

 12:30-13:45

Lunch

Session Three

Update on Genetic Testing and Provision of Genetic Services

 13:45-14:05

What the UK GTN can offer Ophthalmology – Jo Whittaker,Cambridge

 14:05-14:20

Update on Genetics of AMD – Andrew Webster, UCL

 14:20-14:40

Should there be Genetic Testing for AMD?  Discussion to be led by Alan Wright, Edinburgh

 14:40-15:30

Update of Genetic Testing(i) XLRP/ADRP – Niki Hart-Holden, Manchester, James O’Sullivan, Manchester

(ii) Open Discussion:  Who Should Pay for Genetic Testing? – to be chaired by Susie Downes